Merck KGaA, Pfizer (PFE) Report EMA's CHMP Issued Positive Opinion for Avelumab for Treatment of mMCC Jul 21, 2017 07:52AM
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma Jul 21, 2017 07:50AM
100 Healthy Years - Are Kids Prepared? May 19, 2017 04:00AM
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017 May 17, 2017 05:00PM
Merck KGaA, Pfizer (PFE) Announce FDA Approval for BAVENCIO for Common Type of Advanced Bladder Cancer May 9, 2017 03:56PM


May 9, 2017 03:53PM FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Mar 23, 2017 05:30PM FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Dec 6, 2016 09:00AM Merck's Consumer Health Business Drives Consumer-Centric, Purposeful Innovation
Nov 29, 2016 08:21AM FDA Accepts BLA for Avelumab for Treatment of MCC for Priority Review (PFE)
Nov 29, 2016 08:17AM FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
Oct 31, 2016 03:00AM European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Feb 22, 2016 11:30AM Merck Puts Spotlight on Women's Health and Well-being
Sep 29, 2015 08:10AM EMD Serono Joins Industry Leaders for The Economist Events' War On Cancer Forum in Boston